Lamprene (clofazimine)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
PLR Conversion; refer to label.
CONTRAINDICATIONS (addition)
LAMPRENE is contraindicated in patients with known...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology